-
When new members enroll in one of Blue Cross and Blue Shield of Oklahomas (BCBSOK) health promotion programs, they receive free equipment to help them monitor their chronic disease.
-
Thanks to wireless technology, case managers working in Chicagos poorest neighborhoods no longer have lengthy waits to get referrals to other agencies for their clients.
-
The recent report on assisted reproductive technology (ART) by the Presidents Council on Bioethics has been drawing a favorable reception from groups advocating womens health and reproductive choice.
-
A study shows only 50%-60% get recommended care. A recent analysis of data collected by the RAND Corp, a Santa Monica, CA-based health policy think tank, indicates that people in all parts of the nation are at risk for receiving poor health care.
-
Although the researchers themselves focused on deficiencies in the delivery of health care, officials with the nonprofit consumer protection group, Public Citizen, claim the new analysis of health care quality conducted by the RAND Corp. demonstrates that the malpractice insurance crisis is not as great as tort reform advocates claim.
-
According to newly released survey data from the Huntington Valley, PA-based Institute for Safe Medication Practices (ISMP), intimidating behavior is a common element of many health care practice settings, and such behavior is a factor in the occurrence of many medication errors.
-
Mediation long has been known as an alternative way of resolving civil legal disputes. But as the following case study illustrates, it is emerging as a new way to help resolve conflicts in medical settings.
-
From an IRB members perspective, these are trying times. On the one hand, investigators complain that regulations for human subjects research and IRBs are too stringent, making it difficult for them to do their studies. Alternatively, human subjects advocates continually complain that IRBs and institutions are too lax in monitoring clinical studies.
-
Since 1996, the Food and Drug Administration (FDA) has received reports of more than 110 adverse events related to absorbable hemostatic agents, including 11 that resulted in paralysis or other neural deficits.
-
The Department of Health and Human Services Office of Inspector General (OIG) has reported that the $150 Medicare payment for intraocular lenses (IOLs) is more than the cost of IOLs to surgery centers. OIG recommends that the Medicare payment be reduced in a manner that consider the different types and costs of IOLs.
